MannKind Corporation to Present at the RBC Capital Markets Global Healthcare Conference
Get Alerts MNKD Hot Sheet
Join SI Premium – FREE
VALENCIA, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at the 2015 RBC Capital Markets Global Healthcare Conference on Wednesday, February 25, 2015 at 9:00 AM (ET) at the New York Palace in New York City.
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
CONTACT: Company Contact: Matthew J. Pfeffer Corporate Vice President and Chief Financial Officer (661) 775-5300 [email protected]Source: MannKind Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korro Bio (KRRO) Announces $70M Placement
- Warrantee (WRNT) Receives Nasdaq Delisting Determination
- Cosmos Health (COSM) Receives Nasdaq Notice on Late Filing of Its Form 10-K
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!